Curing Type 1 diabetes could be Canada’s legacy

From insulin to regenerative therapy, Canada’s contribution to diabetes research is unmatched. The question is whether we’ll continue to lead or watch others cross the finish line.

Health Minister Marjorie Michel, left. When Canada leads in bioscience, everyone benefits, write Jessica Diniz and Cate Murray. The Hill Times photograph by Andrew Meade and Pexels photograph by Nataliya Vaitkevich

Opinion

BY JESSICA DINIZ, CATE MURRAY

October 30, 2025

A century ago, a Canadian discovery changed the world. After Frederick Banting and Charles Best isolated insulin at the University of Toronto in 1921, a diagnosis of Type 1 diabetes stopped being a death sentence. Before insulin, most patients survived barely two years; now,...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy